drug · antibody

sabirnetug

Phase 2updated 3mo ago

by $ABOS Acumen Pharmaceuticals, Inc.🔗 ChEMBL

Phase 2

community read0 votes

Antibody drug with a maximum clinical stage of Phase 2, with 1 investigational indication.

indications

Alzheimer's Disease

all catalysts(0)

nothing on the calendar yet

Trials studying sabirnetug

phase2A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)active not recruitingn=542
phase1A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participantscompletedn=28

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 35m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · antibody

save

sabirnetug

Phase 2updated 3mo ago

by $ABOS Acumen Pharmaceuticals, Inc.🔗 ChEMBL

Phase 2

community read0 votes

Antibody drug with a maximum clinical stage of Phase 2, with 1 investigational indication.

indications

Alzheimer's Disease

all catalysts(0)

nothing on the calendar yet

Trials studying sabirnetug

phase2A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)active not recruitingn=542
phase1A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participantscompletedn=28

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 35m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

sabirnetug

indications

all catalysts(0)

Trials studying sabirnetug

News(0)

Report a data issue

comments(0)

sabirnetug

indications

all catalysts(0)

Trials studying sabirnetug

News(0)

Report a data issue

comments(0)